EUVIMEDObjevte EUVIMED
Crossref

Evaluation of linagliptin and insulin combined therapy on unfolded protein response in type 1 diabetic mouse heart

Züleyha Doğanyiğit iD, Aslı Okan, Serpil Taheri, Zeynep Yılmaz, Enes Akyüz, Necdet Demir

Chemical Biology & Drug Design · 2023-11 · 102 (5) · 1085-1096

DOI: 10.1111/cbdd.14308 ↗

At a glance

Journal article in Chemical Biology & Drug Design, published online on 2023-08-02. Written by Züleyha Doğanyiğit and 5 co-authors. Institution: Faculty of Medicine, Department of Histology and Embryology, Yozgat Bozok University, Yozgat, Turkey. Major MEDLINE topics: Diabetes Mellitus, Type 1, Dipeptidyl-Peptidase IV Inhibitors. Cited 3 times so far (Crossref); 39 references. Funded by: Bozok Üniversitesi.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

The aim of this study is to reveal the effects of the use of linagliptin, a DPP‐4 inhibitor due to its beneficial cardiovascular effects, on endoplasmic reticulum stress (ERS) signaling, which is involved in the pathogenesis of cardiovascular complications related to type 1 diabetes. BALB/c female mice ( n = 72) were divided into six groups: control, diabetes+insulin, diabetes+linagliptin, diabetes+linagliptin+insulin, diabetes+TUDCA, and diabetes+TUDCA+insulin. Immunohistochemistry and western blot method, qRT‐PCR, ELISA method, and malondialdehyde (MDA) measurements were performed. Linagliptin administered to the type 1 diabetic mouse heart significantly reduced the expression levels of the total and cleaved forms of ATF6, ATF4, and p‐JNK, caspase 3. Immunohistochemical and western blot analyses revealed that cleaved caspase 3 protein expression was significantly increased in the diabetes+insulin group compared to the other groups. According to ELISA findings, TUDCA was more effective in reducing NOX 1 and MDA levels than linagliptin. While linagliptin decreased the Chop mRNA level, no change was observed in the Grp78 mRNA level. Our findings showed that there was not much difference between the administration of linagliptin alone or in combination with insulin. Our study reveals that linagliptin is an effective therapeutic agent on ERS and apoptotic UPR in type 1 diabetic hearts.

Subjects

MeSH terms (MEDLINE)

Diabetes Mellitus, Type 1Dipeptidyl-Peptidase IV InhibitorsMiceAnimalsFemaleLinagliptinInsulinCaspase 3Unfolded Protein ResponseRNA, MessengerTaurochenodeoxycholic Acid

Author keywords

DPP-4 inhibitorlinagliptinmousetype 1 diabetes mellitusunfolded protein response

Substances

LinagliptinInsulinCaspase 3Dipeptidyl-Peptidase IV InhibitorsRNA, MessengerursodoxicoltaurineTaurochenodeoxycholic Acid

Authors and institutions

  • Faculty of Medicine, Department of Histology and Embryology, Yozgat Bozok University, Yozgat, Turkey.
  • Faculty of Medicine, Department of Medical Biology, Erciyes University, Kayseri, Turkey.
  • Faculty of International Medicine, Department of Biophysics, University of Health Sciences, Istanbul, Turkey.
  • Faculty of Medicine, Department of Histology and Embryology, Akdeniz University, Antalya, Turkey.

ORCID profiles: Züleyha Doğanyiğit

Funding

  • Bozok Üniversitesi

Cite

APA

Doğanyiğit, Z., Okan, A., Taheri, S., Yılmaz, Z., Akyüz, E., & Demir, N. (2023). Evaluation of linagliptin and insulin combined therapy on unfolded protein response in type 1 diabetic mouse heart. Chemical Biology & Drug Design, 102(5), 1085-1096. https://doi.org/10.1111/cbdd.14308

Vancouver

Doğanyiğit Z, Okan A, Taheri S, Yılmaz Z, Akyüz E, Demir N. Evaluation of linagliptin and insulin combined therapy on unfolded protein response in type 1 diabetic mouse heart. Chemical Biology & Drug Design. 2023;102(5):1085-1096. doi:10.1111/cbdd.14308

BibTeX
@article{Doanyiit2023,
  author = {Doğanyiğit, Züleyha and Okan, Aslı and Taheri, Serpil and Yılmaz, Zeynep and Akyüz, Enes and Demir, Necdet},
  title = {Evaluation of linagliptin and insulin combined therapy on unfolded protein response in type 1 diabetic mouse heart},
  journal = {Chemical Biology & Drug Design},
  year = {2023},
  volume = {102},
  number = {5},
  pages = {1085--1096},
  doi = {10.1111/cbdd.14308}
}
Start for free →